# Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome

> **NCT03586089** · NA · TERMINATED · sponsor: **Unity Health Toronto** · enrollment: 8 (actual)

## Conditions studied

- Alcohol Withdrawal Delirium
- Alcohol Withdrawal
- Alcohol Withdrawal Seizures

## Interventions

- **DRUG:** Phenobarbital Sodium
- **DRUG:** Inactive placebo

## Key facts

- **NCT ID:** NCT03586089
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-11
- **Primary completion:** 2023-07-17
- **Final completion:** 2023-07-17
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Difficulty recruiting patients
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03586089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03586089, "Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03586089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*